XML 51 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Convertible Senior Notes (Tables)
6 Months Ended
Jun. 30, 2016
Convertible Senior Notes.  
Schedule of the unsecured convertible senior notes outstanding

The following summarizes the unsecured convertible senior notes (collectively, the “Convertible Notes”) outstanding as of June 30, 2016 (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

 

    

 

    

 

    

 

    

Remaining

 

 

 

Principal

 

Coupon

 

Effective

 

Conversion

 

Maturity

 

Period of

 

 

 

Amount

 

Rate

 

Rate(1)

 

Rate(2)

 

Date

 

Amortization

 

2017 Notes

 

$

431,250

 

3.75

%  

5.87

%  

41.7397

 

10/15/2017

 

1.3

years

 

2018 Notes

 

$

599,981

 

4.55

%  

6.10

%  

46.7513

 

3/1/2018

 

1.7

years

 

2019 Notes

 

$

341,363

 

4.00

%  

5.35

%  

49.4927

 

1/15/2019

 

2.5

years

 

 

 

 

 

 

 

 

 

 

 

 

 

As of

 

As of

 

 

    

June 30, 2016

    

December 31, 2015

 

Total principal

 

$

1,372,594

 

$

1,372,594

 

Unamortized discount

 

 

(37,055)

 

 

(47,351)

 

Unamortized deferred financing costs

 

 

(1,115)

 

 

(1,448)

 

Carrying amount of debt components

 

$

1,334,424

 

$

1,323,795

 

Carrying amount of conversion option equity components recorded in additional paid-in capital

 

$

46,343

 

$

46,343

 


(1)

Effective rate includes the effects of underwriter purchase discount and the adjustment for the conversion option, the value of which reduced the initial liability and was recorded in additional paid-in-capital.

 

(2)

The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of Convertible Notes converted, as adjusted in accordance with the indentures governing the Convertible Notes (including the applicable supplemental indentures) as a result of the spin-off of our former single family residential (“SFR”) segment to our stockholders in January 2014 and cash dividend payments.